256 related articles for article (PubMed ID: 34958505)
41. Spindle cell rhabdomyosarcoma in adults: clinicopathological and immunohistochemical analysis of seven new cases.
Mentzel T; Kuhnen C
Virchows Arch; 2006 Nov; 449(5):554-60. PubMed ID: 17013628
[TBL] [Abstract][Full Text] [Related]
42. Detection and clinical significance of bone marrow involvement in patients with rhabdomyosarcoma.
Krsková L; Mrhalová M; Hilská I; Sumerauer D; Drahokoupilová E; Múdry P; Kodet R
Virchows Arch; 2010 May; 456(5):463-72. PubMed ID: 20405298
[TBL] [Abstract][Full Text] [Related]
43. Extremity rhabdomyosarcoma: biological principles, staging, and treatment.
LaQuaglia MP
Semin Surg Oncol; 1993; 9(6):510-9. PubMed ID: 8284570
[TBL] [Abstract][Full Text] [Related]
44. Genomic profiling of pleomorphic rhabdomyosarcoma reveals a genomic signature distinct from that of embryonal rhabdomyosarcoma.
Saoud C; Dermawan JK; Sharma AE; Tap W; Wexler LH; Antonescu CR
Genes Chromosomes Cancer; 2024 May; 63(5):e23238. PubMed ID: 38722224
[TBL] [Abstract][Full Text] [Related]
45. Cytogenetic and Molecular Study of an Adult Sclerosing Rhabdomyosarcoma of the Extremity:
Gorunova L; Bjerkehagen B; Micci F; Heim S; Panagopoulos I
Cancer Genomics Proteomics; 2020; 17(5):563-569. PubMed ID: 32859634
[TBL] [Abstract][Full Text] [Related]
46. Molecular diagnostics in the management of rhabdomyosarcoma.
Arnold MA; Barr FG
Expert Rev Mol Diagn; 2017 Feb; 17(2):189-194. PubMed ID: 28058850
[TBL] [Abstract][Full Text] [Related]
47. [Sclerosing rhabdomyosarcoma: a clinicopathologic study of four cases with review of literature].
Zhu L; Wang J
Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):587-91. PubMed ID: 18070445
[TBL] [Abstract][Full Text] [Related]
48. Testicular fusocellular rhabdomyosarcoma as a metastasis of elbow sclerosing rhabdomyosarcoma: A clinicopathologic, immunohistochemical and molecular study of one case.
Martorell M; Ortiz CM; Garcia JA
Diagn Pathol; 2010 Aug; 5():52. PubMed ID: 20701800
[TBL] [Abstract][Full Text] [Related]
49. Primary alveolar rhabdomyosarcoma of the bone: two cases and review of the literature.
Balogh P; Bánusz R; Csóka M; Váradi Z; Varga E; Sápi Z
Diagn Pathol; 2016 Oct; 11(1):99. PubMed ID: 27756397
[TBL] [Abstract][Full Text] [Related]
50. [Congenital spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological analysis].
Xu JT; Fu LB; Yao XF; Jia C; Guan XX; Zhang M; He LJ
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):344-350. PubMed ID: 38556817
[No Abstract] [Full Text] [Related]
51. Histopathological classification of childhood rhabdomyosarcomas: relationship with clinical parameters and prognosis.
Wijnaendts LC; van der Linden JC; van Unnik AJ; Delemarre JF; Voute PA; Meijer CJ
Hum Pathol; 1994 Sep; 25(9):900-7. PubMed ID: 8088765
[TBL] [Abstract][Full Text] [Related]
52. Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma.
Szuhai K; de Jong D; Leung WY; Fletcher CD; Hogendoorn PC
J Pathol; 2014 Feb; 232(3):300-7. PubMed ID: 24272621
[TBL] [Abstract][Full Text] [Related]
53. Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma.
Dias P; Parham DM; Shapiro DN; Webber BL; Houghton PJ
Am J Pathol; 1990 Dec; 137(6):1283-91. PubMed ID: 2260621
[TBL] [Abstract][Full Text] [Related]
54. Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases.
Xu B; Suurmeijer AJH; Agaram NP; Zhang L; Antonescu CR
Histopathology; 2021 Sep; 79(3):347-357. PubMed ID: 33382123
[TBL] [Abstract][Full Text] [Related]
55. [Clinicopathological study of 145 childhood rhabdomyosarcoma cases].
He LJ; Wang L; Sun N; Huang CR; Zhu XD; Lang ZQ
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):225-8. PubMed ID: 15256113
[TBL] [Abstract][Full Text] [Related]
56. [Rhabdomyosarcoma in middle to old-aged patients: analysis of clinicopathological features and prognosis in 76 cases].
Yu L; Wang J
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):910-6. PubMed ID: 23336377
[TBL] [Abstract][Full Text] [Related]
57. Spindle Cell/Sclerosing Rhabdomyosarcoma With
Rakheja D; Park JY; Alhasan M; Uddin N
Int J Surg Pathol; 2022 Dec; 30(8):950-955. PubMed ID: 35466752
[TBL] [Abstract][Full Text] [Related]
58. Establishment and characterization of NCC-ssRMS1-C1: a novel patient-derived spindle-cell/sclerosing rhabdomyosarcoma cell line.
Yoshimatsu Y; Noguchi R; Tsuchiya R; Sei A; Sugaya J; Iwata S; Sugiyama M; Yoshida A; Kawai A; Kondo T
Hum Cell; 2020 Jul; 33(3):886-893. PubMed ID: 32300959
[TBL] [Abstract][Full Text] [Related]
59. Establishment and characterization of NCC-ssRMS2-C1: a novel patient-derived cell line of spindle cell/sclerosing rhabdomyosarcoma.
Tsuchiya R; Yoshimatsu Y; Noguchi R; Sin Y; Ono T; Sei A; Takeshita F; Sugaya J; Nakatani F; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2021 Sep; 34(5):1569-1578. PubMed ID: 34164773
[TBL] [Abstract][Full Text] [Related]
60. Gene alterations and apoptosis in rhabdomyosarcoma.
Boman F; Brel D; Antunes L; Alhamany Z; Floquet J; Boccon-Gibod L
Pediatr Pathol Lab Med; 1997; 17(2):233-47. PubMed ID: 9086530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
